GABAPENTIN
- Product NDC
- 71610-090
- 11-digit product format
- 716100090
- Labeler code
- 71610
- Product ID
- 71610-090_e8823da8-3545-4630-a3cc-b9dd9aa548d1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA204989
- Marketing category
- ANDA
- Marketing start
- 2016-09-30
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-090 | GABAPENTIN CAPSULE [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20180713_718544b1-092f-4279-a852-b5337092e18f.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-090-53 | 71610009053 | 60 CAPSULE in 1 BOTTLE (71610-090-53) | 60 capsule | 2018-06-25 | 0000-00-00 | No | No | Current |
| 71610-090-60 | 71610009060 | 90 CAPSULE in 1 BOTTLE (71610-090-60) | 90 capsule | 2018-06-25 | 0000-00-00 | No | No | Current |
| 71610-090-80 | 71610009080 | 180 CAPSULE in 1 BOTTLE (71610-090-80) | 180 capsule | 2018-06-25 | 0000-00-00 | No | No | Current |
| 71610-090-92 | 71610009092 | 270 CAPSULE in 1 BOTTLE (71610-090-92) | 270 capsule | 2018-06-25 | 0000-00-00 | No | No | Current |
| 71610-090-94 | 71610009094 | 360 CAPSULE in 1 BOTTLE (71610-090-94) | 360 capsule | 2018-06-25 | 0000-00-00 | No | No | Current |